NCT06759389 · CoLabs Medical
The VENTOR Clinical Study
(VENTOR)
What this study is about
To evaluate the initial safety and effectiveness of the Ventor Airway System in providing short-term ventilation support in non-breathing subjects during cardiopulmonary resuscitation (CPR) and respiratory arrests.
View original scientific description
To evaluate the initial safety and effectiveness of the Ventor Airway System in providing short-term ventilation support in non-breathing subjects during cardiopulmonary resuscitation (CPR) and respiratory arrests.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Adults aged 18-75 years, inclusive
- IHCA (non-traumatic)
- At least 4 feet in height
Exclusion criteria
- Intubated with an endotracheal tube (ET)
- Valid do-not-attempt-resuscitation (DNAR) or study opt-out bracelet (including previous enrollment bracelet)
- LAR or Family member objects to enrollment
- Obvious signs of irreversible death (rigor mortis, dependent lividity, decapitation, transection, decomposition)
- Responsive with an intact gag reflex
- Blunt, penetrating, or burn-related injury, drowning, or electrocution
- Known upper airway foreign body or mass
- Lower airway obstruction
- Dental gap of \< 2 cm
- Ingested caustic substances
- Medicine Admitting Note's medical history is incomplete or has only been completed by an emergency physician.
- Known esophageal disease or facial/perforating neck trauma defined as study candidates with the following medical history:
- Diseases: (Esophageal Varices, Esophageal Cancer, Esophageal Strictures)
- Any patient on the following medications will be excluded: (Oxaliplatin, Leucovorin, Fluorouracil)
- Any patient with the following examination findings will be excluded: (Caput medusae, History or evidence of vomiting blood)
- Known vulnerable subject other Inclusion #3, such as known (e.g.: prisoner, pregnancy, terminal illness, dementia)
- History of medical, surgical or other conditions that, in the opinion of the investigator, would limit study participation
Where
- Stony Brook, New York
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Jun 11, 2025 · Source of record for eligibility and locations